Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter de Ruijter

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Journal of the American Geriatrics Society|May 28, 2009
Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of nonagenariansBert Vaes, Wouter de Ruijter, Jan Degryse, et al.
Age (Dordrecht, Netherlands)|May 9, 2014
Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus studyPetra G van Peet, Anton J M de Craen, Jacobijn Gussekloo, et al.
Anesthesiology|November 2, 2002
Negative and positive inotropic effects of propofol via L-type calcium channels and the sodium-calcium exchanger in rat cardiac trabeculaeWouter de Ruijter, Ger J M Stienen, Jan van Klarenbosch, et al.
Scandinavian Journal of Primary Health Care|July 9, 2008
The additional value of routine electrocardiograms in cardiovascular risk management of older peopleWouter De Ruijter, Willem J J Assendelft, Peter W Macfarlane, et al.
Stroke|May 21, 2013
Framingham stroke risk score and cognitive impairment for predicting first-time stroke in the oldest oldBehnam Sabayan, Jacobijn Gussekloo, Wouter de Ruijter, et al.
BMC Medical Education|October 11, 2011
How learning style affects evidence-based medicine: a survey studySandra E Zwolsman, Nynke van Dijk, Anita A H Verhoeven, et al.
Plos One|November 27, 2013
NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus StudyPetra G van Peet, Yvonne M Drewes, Anton J M de Craen, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 31, 2009
Time trends in preventive drug treatment after myocardial infarction in older patientsWouter de Ruijter, Margot W M de Waal, Jacobijn Gussekloo, et al.
Patient Preference and Adherence|June 6, 2017
Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patientsClare H Luymes, Nelleke J Boelhouwer, Rosalinde Ke Poortvliet, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 27, 2013
Deliberating clinical research with cognitively impaired older people and their relatives: an ethical add-on study to the protocol "Effects of Temporary Discontinuation of Antihypertensive Treatment in the Elderly (DANTE) with Cognitive Impairment"Arendina E van Rookhuijzen, Dorothea P Touwen, Wouter de Ruijter, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Journal of the American Geriatrics Society|May 28, 2009
Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of nonagenariansBert Vaes, Wouter de Ruijter, Jan Degryse, et al.
Age (Dordrecht, Netherlands)|May 9, 2014
Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus studyPetra G van Peet, Anton J M de Craen, Jacobijn Gussekloo, et al.
Anesthesiology|November 2, 2002
Negative and positive inotropic effects of propofol via L-type calcium channels and the sodium-calcium exchanger in rat cardiac trabeculaeWouter de Ruijter, Ger J M Stienen, Jan van Klarenbosch, et al.
Scandinavian Journal of Primary Health Care|July 9, 2008
The additional value of routine electrocardiograms in cardiovascular risk management of older peopleWouter De Ruijter, Willem J J Assendelft, Peter W Macfarlane, et al.
Stroke|May 21, 2013
Framingham stroke risk score and cognitive impairment for predicting first-time stroke in the oldest oldBehnam Sabayan, Jacobijn Gussekloo, Wouter de Ruijter, et al.
BMC Medical Education|October 11, 2011
How learning style affects evidence-based medicine: a survey studySandra E Zwolsman, Nynke van Dijk, Anita A H Verhoeven, et al.
Plos One|November 27, 2013
NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus StudyPetra G van Peet, Yvonne M Drewes, Anton J M de Craen, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 31, 2009
Time trends in preventive drug treatment after myocardial infarction in older patientsWouter de Ruijter, Margot W M de Waal, Jacobijn Gussekloo, et al.
Patient Preference and Adherence|June 6, 2017
Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patientsClare H Luymes, Nelleke J Boelhouwer, Rosalinde Ke Poortvliet, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 27, 2013
Deliberating clinical research with cognitively impaired older people and their relatives: an ethical add-on study to the protocol "Effects of Temporary Discontinuation of Antihypertensive Treatment in the Elderly (DANTE) with Cognitive Impairment"Arendina E van Rookhuijzen, Dorothea P Touwen, Wouter de Ruijter, et al.
Pageof 9